Number of pages: 100 | Report Format: PDF | Published date: January 17, 2024
Historical Years – 2023 | Base Year – 2023 | Forecasted Years – 2024-2032
According to the deep-dive market assessment study by Growth Plus Reports, the global joint pain injections market was valued at US$ 5.04 billion in 2023 and is expected to register a revenue CAGR of 8.37% to reach US$ 10.39 billion by 2032.
Joint Pain Injections Market Fundamentals
Joint pain injections, or intra-articular injections, are medical procedures in which medications are injected directly into the affected joint to relieve pain and inflammation. These injections commonly treat arthritis, bursitis, and other inflammatory joint disorders. Corticosteroids, potent anti-inflammatory agents that help reduce swelling, pain, and joint stiffness, are commonly used in injections.
A medical practitioner performs the procedure, which frequently includes imaging modalities such as ultrasound or fluoroscopy to ensure precise medication delivery into the joint space. When oral medications or conservative treatments are ineffective, corticosteroid joint pain injections provide targeted relief by reducing inflammation and swelling. Although the effects are temporary, these injections are an important component of a comprehensive treatment strategy, promoting improved joint function and quality of life in people with chronic joint pain.
Joint Pain Injections Market Dynamics
The global joint pain injections market revenue is growing with rapid expansion propelled by a convergence of biological and business factors. The demographic shift towards an aging population, coupled with the increasing incidence of chronic pain conditions like osteoarthritis and musculoskeletal disorders, underscores a heightened demand for innovative pain management solutions. According to the 2022 WHO report, approximately 1.71 billion people suffer from musculoskeletal conditions worldwide. Technological advancements in injection techniques augment precision and safety, catering to the preferences of both healthcare practitioners and patients within this evolving landscape. The prevailing inclination towards minimally invasive interventions further enhances the market appeal of joint pain injections, positioning them as targeted therapeutic alternatives that obviate the need for extensive surgical procedures.
Globally, increased healthcare expenditures and enhanced reimbursement frameworks facilitate broader accessibility to joint pain injection therapies. Persistent research and development endeavors, alongside collaborations and partnerships within the healthcare sector, actively contribute to the ongoing refinement of joint pain injection technologies. For instance, Seikagaku Corporation's ‘JOYCLU’ received manufacturing and marketing approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) in March 2021 to treat osteoarthritis. The market for joint pain injections is anticipated expected to sustain its strength as globalization enhances the availability of standardized healthcare services.
The market encounters challenges such as the transient efficacy of injections, infection risk, and potential adverse effects like immune suppression. Also, factors such as limited applicability in widespread pain, patient preferences, healthcare access disparities, and regulatory compliance issues affect market dynamics. Additionally, cost considerations, reimbursement challenges, and the emergence of alternative therapies pose business obstacles.
The global joint pain injections market is analyzed from four the following perspectives: by types, applications, distribution channels, and regions.
Joint Pain Injections Market by Types
Based on types, the global joint pain injections market is segmented into corticosteroid injections, hyaluronic acid injections, platelet rich plasma injections, and others.
Hyaluronic acid injections dominate the global joint pain injections market with the largest revenue share due to their distinct biological characteristics. These injections, which act as a natural joint lubricant, provide long-term relief by restoring synovial fluid in joints and are especially effective in conditions such as osteoarthritis. Their anti-inflammatory properties reduce joint inflammation while also improving function. Hyaluronic acid injections have fewer systemic side effects than other pain medications as a non-opioid alternative, which contributes to their popularity. Their market dominance is due to the ease of administration, adaptability across various joints, and a proven track record. The global aging population and patient preferences highlight the growing demand for hyaluronic acid injections as a critical solution for effective and secure joint pain management.
Joint Pain Injections Market by Application
Based on application, the global joint pain injections market is segmented into knee & ankle, hip joint, shoulder & elbow, and others.
The knee and ankle segment leads the global joint pain injections market with the highest revenue share due to the increased occurrence of osteoarthritis and rheumatoid arthritis, which primarily affect these weight-bearing joints. Given the tendency of these areas for pain and inflammation, injections are frequently used to manage pain. The prevalence of sports-related injuries, as well as advancements in injection techniques and the development of targeted therapies, have all contributed to the segment's prominence. Under stress, the knees and ankles emerge as the primary focal points for pain relief interventions. The efficacy and precision of injections in addressing localized pain and inflammation in these joints boost their market dominance, meeting a significant demand for efficient solutions in managing joint-related discomfort.
Joint Pain Injections Market by Distribution Channel
Based on the distribution channel, the global joint pain injections market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
The hospital pharmacy sector dominates the global joint pain injection market due to its crucial role in healthcare. As primary treatment hubs, hospitals administer joint pain injections to a diverse patient base with acute and chronic conditions. Their specialized medical personnel, advanced facilities, and versatile inpatient/outpatient setups ensure precise and targeted pain management. Hospitals leverage centralized procurement, collaborating with pharmaceutical companies for joint pain injections. Offering comprehensive healthcare services and integration into larger healthcare systems, hospital pharmacies serve as all-encompassing solutions for pain management. Adherence to stringent regulatory standards establishes trust. The sector's supremacy emanates from hospitals' intrinsic strengths, providing effective, specialized, and centralized care for administering joint pain injections across diverse medical situations.
Joint Pain Injections Market by Region
Based on the region, the joint pain injections market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.
The North America segment leads the global joint pain injections market due to its advanced healthcare infrastructure, high incidence of chronic pain conditions, and a strong focus on research and development. The region's well-defined regulatory framework ensures safety and efficacy standards, contributing to confidence in joint pain injection therapies. Technological advancements, including precision medicine and minimally invasive procedures, enhance the effectiveness of joint pain injections. The significant healthcare spending in the United States supports widespread access to various pain management modalities. A well-educated healthcare workforce and population contribute to a high awareness of pain management options. Additionally, the region's large aging population, characterized by age-related chronic pain, further fuels the demand for joint pain injections.
Strategic Developments Joint Pain Injections Market
Joint Pain Injections Market Competitive Landscape
The competitive landscape in the joint pain injections market is becoming increasingly dynamic and diverse. The key players contend for dominance through innovative formulations, strategic partnerships, and geographic expansions. Factors include product efficacy, regulatory compliance, and market penetration strategies. These companies strive to gain a competitive edge by offering advanced designs, improved surgical techniques, and enhanced patient outcomes.
Some of the prominent companies having the largest revenue share in the global joint pain injections market are,
Joint pain injections involve administering medications directly into a joint to alleviate pain and inflammation.
Sanofi S.A., Bioventus, and Pfizer Inc. are the prominent global market players.
The global joint pain injections market is expected to register a revenue CAGR of 8.37% from 2024 to 2032.
North America accounts for the largest revenue share in the global joint pain injections market.
Restraining factors in the global joint pain injections market include the availability of alternative options and limited treatment options.
*Insights on financial performance are subject to the availability of information in the public domain